Allegion plc (NYSE:ALLE – Get Free Report) was the target of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 1,570,000 shares, a drop of 8.7% from the October 31st total of 1,720,000 shares. Approximately 1.8% of the company’s shares are short sold. Based on an average daily volume of 796,700 shares, the days-to-cover ratio is presently 2.0 days.
Allegion Stock Performance
Shares of NYSE:ALLE traded up $0.65 during trading on Wednesday, reaching $141.14. The company had a trading volume of 130,635 shares, compared to its average volume of 724,646. The firm has a market capitalization of $12.27 billion, a price-to-earnings ratio of 21.58, a price-to-earnings-growth ratio of 3.35 and a beta of 1.10. The company has a debt-to-equity ratio of 1.26, a current ratio of 1.71 and a quick ratio of 1.29. The stock’s fifty day moving average price is $143.77 and its 200 day moving average price is $133.11. Allegion has a fifty-two week low of $104.25 and a fifty-two week high of $156.10.
Allegion (NYSE:ALLE – Get Free Report) last released its earnings results on Thursday, October 24th. The scientific and technical instruments company reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.98 by $0.18. Allegion had a return on equity of 45.64% and a net margin of 15.36%. The business had revenue of $967.10 million for the quarter, compared to analyst estimates of $970.70 million. During the same quarter in the previous year, the company posted $1.94 earnings per share. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year. As a group, equities research analysts predict that Allegion will post 7.41 EPS for the current year.
Allegion Announces Dividend
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on ALLE shares. Wells Fargo & Company boosted their price target on Allegion from $137.00 to $152.00 and gave the stock an “equal weight” rating in a research note on Monday, October 7th. Mizuho boosted their price target on Allegion from $135.00 to $150.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Robert W. Baird boosted their price target on Allegion from $145.00 to $152.00 and gave the stock a “neutral” rating in a research note on Friday, October 25th. Finally, Barclays boosted their price target on Allegion from $135.00 to $137.00 and gave the stock an “underweight” rating in a research note on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $144.60.
Get Our Latest Stock Report on ALLE
Insider Transactions at Allegion
In related news, SVP Robert C. Martens sold 8,035 shares of Allegion stock in a transaction dated Friday, October 25th. The stock was sold at an average price of $144.92, for a total value of $1,164,432.20. Following the completion of the sale, the senior vice president now directly owns 7,104 shares in the company, valued at $1,029,511.68. The trade was a 53.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.
Institutional Trading of Allegion
A number of institutional investors have recently bought and sold shares of the company. McClarren Financial Advisors Inc. lifted its position in shares of Allegion by 61.0% in the third quarter. McClarren Financial Advisors Inc. now owns 190 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 72 shares in the last quarter. Brooklyn Investment Group purchased a new stake in shares of Allegion in the third quarter valued at $28,000. Crewe Advisors LLC lifted its position in shares of Allegion by 160.2% in the second quarter. Crewe Advisors LLC now owns 242 shares of the scientific and technical instruments company’s stock valued at $29,000 after acquiring an additional 149 shares in the last quarter. Concord Wealth Partners purchased a new stake in shares of Allegion in the third quarter valued at $29,000. Finally, Cromwell Holdings LLC lifted its position in shares of Allegion by 65.2% in the third quarter. Cromwell Holdings LLC now owns 233 shares of the scientific and technical instruments company’s stock valued at $34,000 after acquiring an additional 92 shares in the last quarter. 92.21% of the stock is currently owned by hedge funds and other institutional investors.
About Allegion
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.
Recommended Stories
- Five stocks we like better than Allegion
- What is Short Interest? How to Use It
- Tesla Poised to Hit Record Highs This Holiday Season
- What is a support level?
- The Salesforce Rally is Just Getting Started: Here’s Why
- Business Services Stocks Investing
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Allegion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allegion and related companies with MarketBeat.com's FREE daily email newsletter.